John McLaughlin, DO
Adult Reconstructive Orthopaedic Surgery · Cleveland, OHNPI 1992003149
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.0%), education and food and beverage — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 63.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $31,864, more than ten times the $705 reported in 2019.
Across 185 payments — averaging $426.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$50K
- Orthalign Inc$15K
- Smith+Nephew$11K
- Stryker$2K
- Johnson & Johnson$496
- Bone Support Inc.$281
- plus $317 from 4 others
What the payments were for
- Consulting fees$37,85848%
- Speaking & faculty fees$3,1054%
- Travel & lodging$7,92310%
- Food & beverage$7,92510%
- Education$22,04028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 86 | $49,934 |
| Orthalign Inc | 14 | $15,332 |
| Smith+Nephew | 30 | $10,696 |
| Stryker | 39 | $1,794 |
| Johnson & Johnson(2 entities) | 9 | $496 |
| Bone Support Inc. | 2 | $281 |
| Biocomposites Inc | 1 | $135 |
| Medtronic | 1 | $85 |
| Innovation Technologies Inc | 1 | $56 |
| Medical Device Business Services, Inc. | 2 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$24,874
- ROSA$19,680
- ORTHALIGN PLUS$15,142
- BIRMINGHAM HIP$8,566
- REAL INTELLIGENCE$5,941
- Journey II$5,237
- RI.HIP NAVIGATION$5,178
- G7$3,000
- Avenir$3,000
- Journey II BCS$678
- MAKO$590
- REDAPT$469
- OXINIUM Knee$469
- Anthology$469
- R3$469
- CERAMENTBONE VOID FILLER$281
- CERAMENT G$281
- ROSA-Knee$254
- CORI$209
- Legion Revision$209
How this compares
$78,851 in reported general payments places this provider in the 75th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.
See all adult reconstructive orthopaedic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 16 | $1,232 |
| Doxycycline Hyclate | 29 | $1,218 |
| Mupirocin | 138 | $749 |
| Amoxicillin | 150 | $138 |
| Meloxicam | 78 | $109 |
| Clindamycin Hcl | 30 | $76 |
| Baclofen | 14 | $66 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Cleveland
- Viktor KrebsCleveland$7.5M
- Nicolas PiuzziCleveland$1.2M
- Michael BloomfieldCleveland$321K
- Trevor MurrayCleveland$192K
- James VoosCleveland$166K
- Peter SuraceCleveland$146K
- Kim StearnsCleveland$80K
- Mark DenzineCleveland$31K
- Michael KolczunCleveland$22K
- Michael ErossyCleveland$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.